Variant report
Variant | esv2636908 |
---|---|
Chromosome Location | chr1:172827734-172829200 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs148922206 | chr1:172827763-172827764 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs574666619 | chr1:172827781-172827782 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs116728646 | chr1:172827862-172827863 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs76822974 | chr1:172828024-172828025 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs181371283 | chr1:172828095-172828096 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs546324172 | chr1:172828118-172828119 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs573591843 | chr1:172828127-172828128 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs184930017 | chr1:172828128-172828129 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs573283488 | chr1:172828205-172828206 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs540484687 | chr1:172828211-172828212 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs371492253 | chr1:172828223-172828224 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs12131049 | chr1:172828254-172828255 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs529064386 | chr1:172828261-172828262 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs550479969 | chr1:172828270-172828271 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs188126526 | chr1:172828310-172828311 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs368213931 | chr1:172828338-172828339 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs532878090 | chr1:172828339-172828340 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs551466865 | chr1:172828359-172828360 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs74985558 | chr1:172828390-172828391 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs10912482 | chr1:172828413-172828414 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs181022459 | chr1:172828442-172828443 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs578217653 | chr1:172828458-172828459 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs17371133 | chr1:172828480-172828481 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs151018581 | chr1:172828491-172828492 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs369881670 | chr1:172828517-172828518 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs535770906 | chr1:172828546-172828547 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs35559844 | chr1:172828576-172828577 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs367741381 | chr1:172828597-172828598 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs186180277 | chr1:172828609-172828610 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs192446264 | chr1:172828650-172828651 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs539507078 | chr1:172828743-172828744 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs142262833 | chr1:172828782-172828783 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs573246689 | chr1:172828832-172828833 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs540647000 | chr1:172828837-172828838 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs562093305 | chr1:172828894-172828895 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs573981654 | chr1:172828895-172828896 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs544536031 | chr1:172828913-172828914 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs562504718 | chr1:172828993-172828994 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs183303611 | chr1:172829000-172829001 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs551163611 | chr1:172829009-172829010 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs187052853 | chr1:172829016-172829017 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs146042637 | chr1:172829064-172829065 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs548545945 | chr1:172829090-172829091 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs138779412 | chr1:172829136-172829137 | Weak transcription Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21183584 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Rett syndrome | 21593744 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Bladder cancer | 19088036 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chordoma | 18071362 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Breast cancer | 21611746 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Cancer | 17060936 | CNVD |
Lung cancer | 16740712 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Williams-beuren syndrome | 16971481 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 20409316 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:172820600-172840200 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
2 | chr1:172826600-172830400 | Weak transcription | Right Atrium | heart |
3 | chr1:172828400-172828600 | Enhancers | A549 | lung |
4 | chr1:172828400-172828600 | Enhancers | HUVEC | blood vessel |
5 | chr1:172828400-172828800 | Enhancers | HMEC | breast |
6 | chr1:172828400-172828800 | Enhancers | HSMM | muscle |
7 | chr1:172828400-172828800 | Enhancers | NHDF-Ad | bronchial |
8 | chr1:172828600-172828800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
9 | chr1:172828600-172829000 | Enhancers | Muscle Satellite Cultured Cells | -- |
10 | chr1:172828600-172829000 | Enhancers | NH-A | brain |
11 | chr1:172828600-172829000 | Enhancers | Osteobl | bone |
12 | chr1:172828600-172829200 | Enhancers | NHEK | skin |
13 | chr1:172828600-172829400 | Flanking Active TSS | HUVEC | blood vessel |
14 | chr1:172828600-172840600 | Weak transcription | A549 | lung |
15 | chr1:172828800-172840200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |